Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy. 1985

T Matsuishi, and K Hirata, and K Terasawa, and H Kato, and M Yoshino, and E Ohtaki, and F Hirose, and I Nonaka, and N Sugiyama, and K Ohta

Two Japanese siblings had lipid storage myopathy with hypertrophic cardiomyopathy (HCM). They had slowly progressive muscle weakness and ventricular hypertrophy of the heart evidenced by electrocardiography and echocardiography. Their developmental milestones were normal until three years of age when mild weakness in the lower limbs became evident. Laboratory examination showed transient high creatine kinase levels (CK) and hyperammonemia. Histochemical investigation on the muscles revealed abnormal accumulation of sudanophilic lipid droplets predominantly in type 1 fibers, type 2 A fiber atrophy and type 2 B fiber deficiency. In case 1, excessive lipid droplets were also observed in the biopsied cardiac muscle. Carnitine was decreased in the skeletal muscles and the serum. Treatment with DL-carnitine to both cases resulted in marked clinical improvement and decreased lipid droplets in the muscles.

UI MeSH Term Description Entries
D008064 Lipidoses Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved. Lipidosis,Lipoidosis
D008297 Male Males
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009135 Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. Muscle Disorders,Myopathies,Myopathic Conditions,Muscle Disorder,Muscular Disease,Myopathic Condition,Myopathy
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Matsuishi, and K Hirata, and K Terasawa, and H Kato, and M Yoshino, and E Ohtaki, and F Hirose, and I Nonaka, and N Sugiyama, and K Ohta
December 1980, European journal of pediatrics,
T Matsuishi, and K Hirata, and K Terasawa, and H Kato, and M Yoshino, and E Ohtaki, and F Hirose, and I Nonaka, and N Sugiyama, and K Ohta
October 1982, Neurology,
T Matsuishi, and K Hirata, and K Terasawa, and H Kato, and M Yoshino, and E Ohtaki, and F Hirose, and I Nonaka, and N Sugiyama, and K Ohta
June 1981, British medical journal (Clinical research ed.),
T Matsuishi, and K Hirata, and K Terasawa, and H Kato, and M Yoshino, and E Ohtaki, and F Hirose, and I Nonaka, and N Sugiyama, and K Ohta
March 1975, Journal of the neurological sciences,
T Matsuishi, and K Hirata, and K Terasawa, and H Kato, and M Yoshino, and E Ohtaki, and F Hirose, and I Nonaka, and N Sugiyama, and K Ohta
February 1982, Acta neurologica,
T Matsuishi, and K Hirata, and K Terasawa, and H Kato, and M Yoshino, and E Ohtaki, and F Hirose, and I Nonaka, and N Sugiyama, and K Ohta
July 1993, Muscle & nerve,
T Matsuishi, and K Hirata, and K Terasawa, and H Kato, and M Yoshino, and E Ohtaki, and F Hirose, and I Nonaka, and N Sugiyama, and K Ohta
March 1982, Japanese heart journal,
T Matsuishi, and K Hirata, and K Terasawa, and H Kato, and M Yoshino, and E Ohtaki, and F Hirose, and I Nonaka, and N Sugiyama, and K Ohta
February 1977, Journal of neurology, neurosurgery, and psychiatry,
T Matsuishi, and K Hirata, and K Terasawa, and H Kato, and M Yoshino, and E Ohtaki, and F Hirose, and I Nonaka, and N Sugiyama, and K Ohta
August 2012, International journal of cardiology,
T Matsuishi, and K Hirata, and K Terasawa, and H Kato, and M Yoshino, and E Ohtaki, and F Hirose, and I Nonaka, and N Sugiyama, and K Ohta
December 1979, Journal of medical genetics,
Copied contents to your clipboard!